Position in MDGL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$380,697
-$46,454 QoQ
Shares Held
709
-13.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#269
of 411 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CIBC Asset Management Inc holds $114,884,709 across 45 Biotechnology names. MDGL ranks #15 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
104,292 | $51,804,965 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,660 | $25,976,676 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,342 | $8,832,822 | |
| 4 | INCY |
Incyte Corp
|
63,141 | $7,157,663 | |
| 5 | MRNA |
Moderna, Inc.
|
78,815 | $5,519,414 | |
| 6 | TECH |
BIO-TECHNE Corp
|
34,505 | $2,437,778 | |
| 7 | RPRX |
Royalty Pharma plc
|
34,087 | $1,911,258 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
8,768 | $1,642,071 |
All Filings in MDGL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $380,697 | 709 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $427,151 | 816 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $475,189 | 816 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $287,121 | 626 | Shares | Sole | 2025-10-31 | |
| 2025-03-31 | $207,349 | 626 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||